Winning the battle against ICU infections: Preventing ventilator-associated pneumonia (VAP), central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and Clostridium difficile infection (CDI)
Journal of Precision Respiratory Medicine · 01.05.2026 · 9 (1) · 32-40
DOI: 10.2500/jprm.2026.9.260001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Precision Respiratory Medicine, erschienen am 01.05.2026. Verfasst von Meagan Mayo und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Pneumonieprophylaxe, Katheterassoziierte Infektionen
Abstract (Originalsprache)
Background
Hospital-acquired infections (HAI) remain a leading source of preventable morbidity and mortality, and excess health-care expenditure in intensive care units (ICU). Despite substantial advances in infection prevention, central line—associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated events, ventilator-associated pneumonia, and Clostridioides difficile infections continue to cause significant harm. The Centers for Medicare and Medicaid Services (CMS), through the National Healthcare Safety Network, mandates surveillance, and public reporting, linking infection rates to hospital reimbursement and penalties under the Hospital-Acquired Condition Reduction Program. This has intensified pressure on healthcare systems to balance financial accountability and reporting with evidence-based, patient-centered care. These reported patient safety indications impact overall performance and system reputation with raters and rankers. This article reviews the current evidence and guideline-based practices for preventing ICU-related infections, with attention to the nuances of reporting requirements, antimicrobial and diagnostic stewardship, and emerging antimicrobial resistance. In addition, it explores the financial and ethical tensions between administrative reporting requirements and bedside clinical decision-making. We sought to underscore the importance of collaboration among infection prevention specialists, intensivists, and infectious disease physicians while providing the highest quality of bedside patient care.
Methods
We conducted a narrative review of current evidence and guideline-based practices for preventing ICU-related infections. Particular attention was given to reporting requirements, antimicrobial and diagnostic stewardship strategies, and the growing challenge of antimicrobial resistance. We also examined the financial and ethical tensions that arise between administrative reporting obligations and bedside clinical decision-making.
Results
Evidence-based infection prevention strategies including standardized device-care bundles, antimicrobial stewardship, diagnostic stewardship, and multidisciplinary collaboration remain central to reducing ICU-related HAIs. However, regulatory reporting structures and reimbursement-linked metrics may at times create competing priorities between documentation requirements and individualized patient care. Emerging antimicrobial resistance further complicates efforts and underscores the need for coordinated stewardship activities.
Conclusion
Reducing ICU-related healthcare associated infections requires collaboration amongst infection prevention specialists, intensivists, and infectious disease physicians. Healthcare systems must strive to align regulatory requirements with high-quality, patient-centered bedside care. A balanced approach that integrates evidence-based prevention, stewardship principles, and transparent reporting is essential to improving outcomes while maintaining financial and ethical accountability.
Zitieren
APA
Mayo, M., & McWilliams, C. S. (2026). Winning the battle against ICU infections: Preventing ventilator-associated pneumonia (VAP), central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and Clostridium difficile infection (CDI). Journal of Precision Respiratory Medicine, 9(1), 32-40. https://doi.org/10.2500/jprm.2026.9.260001
Vancouver
Mayo M, McWilliams CS. Winning the battle against ICU infections: Preventing ventilator-associated pneumonia (VAP), central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and Clostridium difficile infection (CDI). Journal of Precision Respiratory Medicine. 2026;9(1):32-40. doi:10.2500/jprm.2026.9.260001
BibTeX
@article{Mayo2026,
author = {Mayo, Meagan and McWilliams, Carla Sue},
title = {Winning the battle against ICU infections: Preventing ventilator-associated pneumonia (VAP), central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and Clostridium difficile infection (CDI)},
journal = {Journal of Precision Respiratory Medicine},
year = {2026},
volume = {9},
number = {1},
pages = {32--40},
doi = {10.2500/jprm.2026.9.260001}
}
EUVIMED